Leveda 180 Tablet contains Fexofenadine 180 mg, a second-generation antihistamine used primarily for the relief of allergy symptoms. Fexofenadine acts as a selective peripheral H1 receptor antagonist, effectively reducing the effects of histamine, a substance responsible for allergic manifestations such as sneezing, runny nose, itchy or watery eyes, and urticaria. Leveda 180 is commonly prescribed for the treatment of seasonal allergic rhinitis and chronic idiopathic urticaria, providing symptomatic relief without causing significant sedation due to its limited penetration of the blood-brain barrier. The tablet is administered orally, typically once daily, and is well tolerated with a favorable safety profile. Common side effects may include headache, drowsiness, dry mouth, and nausea, though these are generally mild and transient. Leveda 180 should be used with caution in patients with renal impairment, and dosage adjustments may be necessary. It is contraindicated in individuals with known hypersensitivity to Fexofenadine or any of the tablet’s excipients. Patients are advised to follow the prescribed dosage and consult a healthcare professional before use, especially if pregnant, breastfeeding, or taking other medications to avoid potential drug interactions. Leveda 180 offers effective, non-sedating allergy symptom control, enhancing patient quality of life.